{"id":252606,"date":"2026-09-17T12:45:32","date_gmt":"2026-09-17T07:15:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/"},"modified":"2026-09-17T12:45:32","modified_gmt":"2026-09-17T07:15:32","slug":"bandhan-healthcare-fund-direct-growth-review-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/","title":{"rendered":"Bandhan Healthcare Fund Direct Growth Review 2026: NAV, Returns, Portfolio &#038; Should You Invest?"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/mutual-funds\/bandhan-healthcare-fund-g-direct-plan\">Bandhan Healthcare Fund Direct Growth Plan<\/a> had a NAV of \u20b911.237 as of 16 September 2026 and scheme AUM of \u20b9331 Cr. Its 1-year, 3-year and 5-year returns are 0%, 0% and 0%, and the fund is tagged as High Risk.<\/p>\n<p>Our view is that this is still a young healthcare-focused scheme, so the return record is too short to judge it through a full cycle. The recent numbers and the portfolio make it more suitable for investors who can tolerate sharp swings and want a focused sector exposure rather than a diversified core holding.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#Quick_facts\" title=\"Quick facts\">Quick facts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#Performance\" title=\"Performance\">Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#Should_you_BUY_or_HOLD_Bandhan_Healthcare\" title=\"Should you BUY or HOLD Bandhan Healthcare?\">Should you BUY or HOLD Bandhan Healthcare?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#Peer_comparison\" title=\"Peer comparison\">Peer comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#Portfolio_where_your_money_goes\" title=\"Portfolio: where your money goes\">Portfolio: where your money goes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#Who_should_invest\" title=\"Who should invest\">Who should invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#Tax_and_exit_load\" title=\"Tax and exit load\">Tax and exit load<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#Frequently_asked_questions\" title=\"Frequently asked questions\">Frequently asked questions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#Bottom_line\" title=\"Bottom line\">Bottom line<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#Explore_mutual_funds_with_Univest\" title=\"Explore mutual funds with Univest\">Explore mutual funds with Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/bandhan-healthcare-fund-direct-growth-review-2026\/#RIA_disclosure\" title=\"RIA disclosure\">RIA disclosure<\/a><\/li><\/ul><\/nav><\/div>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Quick_facts\"><\/span>Quick facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Particular<\/th>\n<th>Details<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>NAV<\/td>\n<td>\u20b911.237 as of 16 Sep 2026<\/td>\n<\/tr>\n<tr>\n<td>AUM<\/td>\n<td>\u20b9331 Cr<\/td>\n<\/tr>\n<tr>\n<td>Expense Ratio<\/td>\n<td>0.0%<\/td>\n<\/tr>\n<tr>\n<td>Launch Date<\/td>\n<td>28 Nov 2025<\/td>\n<\/tr>\n<tr>\n<td>Min SIP<\/td>\n<td>\u20b9100<\/td>\n<\/tr>\n<tr>\n<td>Risk Category<\/td>\n<td>High Risk<\/td>\n<\/tr>\n<tr>\n<td>Benchmark<\/td>\n<td>Nifty 50<\/td>\n<\/tr>\n<tr>\n<td>Exit Load<\/td>\n<td>0.50% on or before 30D, Nil after 30D<\/td>\n<\/tr>\n<tr>\n<td>Fund Managers<\/td>\n<td>Viraj Kulkarni, Brijesh Shah, Ritika Behera, Gaurav Satra<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The fund is managed by Viraj Kulkarni, Brijesh Shah, Ritika Behera and Gaurav Satra.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 16 Sep 2026<\/small><\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Performance\"><\/span>Performance<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Period<\/th>\n<th>Fund return<\/th>\n<th>Benchmark return<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1M<\/td>\n<td>-0.64%<\/td>\n<td>-4.41%<\/td>\n<\/tr>\n<tr>\n<td>3M<\/td>\n<td>8.26%<\/td>\n<td>-3.6%<\/td>\n<\/tr>\n<tr>\n<td>1Y<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td>3Y<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td>5Y<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The short-horizon pattern is mixed but constructive. Over one month, the fund was slightly negative while the benchmark was more weakly negative, which means the scheme did not fully escape the market pressure but held up better than the index in that window.<\/p>\n<p>The three-month picture is stronger. The fund returned 8.26% while the benchmark fell 3.6%, so the scheme clearly outpaced the index over that stretch. That gap suggests the portfolio has been able to benefit from healthcare-specific moves even when the broader market was softer.<\/p>\n<p>Because the scheme launched only in November 2025, longer trailing periods are not yet available in a meaningful way. That makes the available history useful for short-term reading, but not enough to build confidence in a full-cycle return pattern. For now, the main takeaway is that near-term behaviour has been better than the benchmark, but the record is still limited.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 16 Sep 2026<\/small><\/p>\n<section class=\"univest-mf-premium-cta\" style=\"margin:28px 0;padding:24px;border-radius:10px;border:1px solid #d8e3f0;background:#f7faff\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Should_you_BUY_or_HOLD_Bandhan_Healthcare\"><\/span>Should you BUY or HOLD Bandhan Healthcare?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A fund&#8217;s past returns alone don&#8217;t tell you whether you should buy it today or continue holding it.<\/p>\n<p>The right decision depends on factors such as your current allocation, purchase price, risk profile, investment horizon and the role this fund plays in your overall portfolio.<\/p>\n<p><strong>Already holding Bandhan Healthcare? Thinking of investing now?<\/strong><\/p>\n<p><a href=\"https:\/\/univest.in\/mutual-funds\" style=\"font-weight:700;text-decoration:none\">Get your portfolio analysed for FREE by SEBI-registered Investment Adviser (RIA) through Univest MF Premium<\/a><\/p>\n<\/section>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Peer_comparison\"><\/span>Peer comparison<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Fund<\/th>\n<th>1Y return<\/th>\n<th>3Y return<\/th>\n<th>5Y return<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/bandhan-healthcare-fund-g-direct-plan\">Bandhan Healthcare Fund Direct Growth Plan<\/a><\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/baroda-bnp-paribas-gold-etf-fof-g-direct-plan\">Baroda BNP Paribas Gold ETF FoF Direct Growth Plan<\/a><\/td>\n<td>34.39%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/hdfc-innovation-fund-g-direct-plan\">HDFC Innovation Fund Direct Growth Plan<\/a><\/td>\n<td>14.3%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/bajaj-finserv-small-cap-fund-g-direct-plan\">Bajaj Finserv Small Cap Fund Direct Growth Plan<\/a><\/td>\n<td>13.33%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/quant-equity-savings-fund-g-direct-plan\">Quant Equity Savings Fund Direct Growth Plan<\/a><\/td>\n<td>8.75%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/kotak-active-momentum-fund-g-direct-plan\">Kotak Active Momentum Fund Direct Growth Plan<\/a><\/td>\n<td>6.31%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>This assessment is prepared by Uniapps Investment Adviser Pvt. Ltd. under SEBI Registered Investment Adviser registration INA000017639.<\/p>\n<p>The fund has no available 1-year trailing return to compare directly with the peer set, while the listed peers show clearly positive 1-year figures. That means the comparison is more useful for context than for a strict like-for-like judgment.<\/p>\n<p>Where the fund does have usable history, the 3-month reading is stronger than the peer figures shown for their 1-year horizons only in the sense that it has beaten the benchmark over that short window, but the peer table does not give a matching 3-month lens. On available 1-year peer numbers, the fund does not yet present a return figure that can be lined up against them.<\/p>\n<p>Because the other schemes also show no available 3-year or 5-year data in this table, the short-term story is stronger than the long-term comparison set here. The main message is that the fund\u2019s track record is still too short for a deep comparison, even though its recent performance has been better than the benchmark.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 16 Sep 2026<\/small><\/p>\n<div class=\"univest-peer-login-cta\" style=\"margin:20px 0;padding:16px 18px;border:1px solid #d8e3f0;border-radius:8px;background:#f7faff\">\n<p style=\"margin:0\"><strong>Want to know more?<\/strong> <a href=\"https:\/\/univest.in\/user\/log-in\" style=\"font-weight:700;text-decoration:none\">Log in to Univest<\/a> for more mutual fund insights.<\/p>\n<\/div>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Portfolio_where_your_money_goes\"><\/span>Portfolio: where your money goes<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Holding<\/th>\n<th>Sector<\/th>\n<th>Weight<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Sun Pharmaceutical Industries Limited<\/td>\n<td>Healthcare<\/td>\n<td>10.48%<\/td>\n<\/tr>\n<tr>\n<td>Cipla Limited<\/td>\n<td>Healthcare<\/td>\n<td>6.38%<\/td>\n<\/tr>\n<tr>\n<td>Max Healthcare Institute Limited<\/td>\n<td>Healthcare<\/td>\n<td>5.81%<\/td>\n<\/tr>\n<tr>\n<td>Apollo Hospitals Enterprise Limited<\/td>\n<td>Healthcare<\/td>\n<td>5.64%<\/td>\n<\/tr>\n<tr>\n<td>Triparty Repo TRP_010926<\/td>\n<td>Cash &amp; Cash Equivalents and Net Assets<\/td>\n<td>4.33%<\/td>\n<\/tr>\n<tr>\n<td>Divi&#8217;S Laboratories Limited<\/td>\n<td>Healthcare<\/td>\n<td>4.28%<\/td>\n<\/tr>\n<tr>\n<td>Aurobindo Pharma Limited<\/td>\n<td>Healthcare<\/td>\n<td>4.14%<\/td>\n<\/tr>\n<tr>\n<td>Lupin Limited<\/td>\n<td>Healthcare<\/td>\n<td>3.96%<\/td>\n<\/tr>\n<tr>\n<td>Shilpa Medicare Limited<\/td>\n<td>Healthcare<\/td>\n<td>3.72%<\/td>\n<\/tr>\n<tr>\n<td>Glaxosmithkline Pharmaceuticals Limited<\/td>\n<td>Healthcare<\/td>\n<td>3.68%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The top 10 holdings account for approximately 52.42% of the portfolio.<\/p>\n<p>To see all holdings, visit the <a href=\"https:\/\/univest.in\/mutual-funds\/bandhan-healthcare-fund-g-direct-plan\">Bandhan Healthcare Fund Direct Growth Plan<\/a> page<\/p>\n<p>The largest holding, Sun Pharmaceutical Industries Limited, carries a 10.48% weight, which is large enough to matter on its own but not so large that it dominates the entire portfolio. The tenth holding still sits at 3.68%, so the drop from the first to the tenth position is noticeable but not extreme.<\/p>\n<p>That shape suggests a portfolio that is still fairly concentrated in a small set of names, especially because the top 10 holdings together account for 52.42% of the portfolio and the scheme discloses 36 holdings overall. The remaining positions likely create a longer tail of smaller exposures, which may reduce single-stock dependence.<\/p>\n<p>At the same time, the healthcare theme is visible across the table, so the fund may be more sensitive to moves within that sector than a diversified equity fund. The cash and cash-equivalent holding also adds a modest stabilising element, but the overall setup still points to a focused portfolio rather than a broad market basket.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 16 Sep 2026<\/small><\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Who_should_invest\"><\/span>Who should invest<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This fund suits investors who can tolerate High Risk and are comfortable with a narrow sector focus. The limited history means it is better viewed as a healthcare allocation with a short performance record rather than a long-established core holding.<\/p>\n<p>The available returns suggest that near-term behaviour can differ from the broader market, and the benchmark comparison shows that the fund has been able to outpace the index in the recent three-month window. The trade-off is clear: investors may get stronger sector-led upside when healthcare is supportive, but they also accept a more concentrated path of returns and a shorter track record.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Tax_and_exit_load\"><\/span>Tax and exit load<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Holding period<\/th>\n<th>Tax rate<\/th>\n<th>Description<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Units held less than 1 year<\/td>\n<td>20%<\/td>\n<td>Short-term capital gains tax<\/td>\n<\/tr>\n<tr>\n<td>Units held more than 1 year<\/td>\n<td>12.5%<\/td>\n<td>Long-term capital gains tax<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Exit load: 0.50% if units are sold on or before 30 days; nil after 30 days.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 16 Sep 2026<\/small><\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Frequently_asked_questions\"><\/span>Frequently asked questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>What is the current NAV of Bandhan Healthcare Fund Direct Growth Plan?<\/strong><br \/>The current NAV is \u20b911.237 as of 16 September 2026.<\/p>\n<p><strong>What are the fund\u2019s recent returns?<\/strong><br \/>The fund\u2019s 1-month return is -0.64% and its 3-month return is 8.26%. The 1-year, 3-year and 5-year figures are not available for this scheme.<\/p>\n<p><strong>How has the fund performed versus the benchmark?<\/strong><br \/>It has done better than the benchmark over 3 months, where the fund returned 8.26% and the benchmark returned -3.6%. Over 1 month, the fund was -0.64% versus -4.41% for the benchmark.<\/p>\n<p><strong>How does the fund compare with peers on available return data?<\/strong><br \/>The peer table shows 1-year gains for the other named funds, while this scheme does not yet have a usable 1-year trailing return. That makes the comparison more useful for context than for a direct like-for-like conclusion.<\/p>\n<p><strong>Is there a minimum SIP?<\/strong><br \/>Yes, the minimum SIP is \u20b9100.<\/p>\n<p><strong>What should investors know about the risk and portfolio?<\/strong><br \/>The fund is tagged High Risk, and its largest holding is Sun Pharmaceutical Industries Limited at 10.48%. The top 10 holdings together account for 52.42% of the portfolio, so the scheme remains fairly focused.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Bottom_line\"><\/span>Bottom line<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bandhan Healthcare Fund Direct Growth Plan has shown a better recent stretch than the benchmark, but the longer record is still too short to judge it across full market cycles. On the available comparison set, its return history is less developed than the peer figures shown, so the main draw is the sector-focused portfolio rather than an established long-term track record. The fund remains High Risk, and the top holdings carry enough weight that stock selection is likely to matter.<\/p>\n<p class=\"univest-posted-at\" style=\"font-size:14px;color:#666;margin:20px 0 8px\">Published on 17 September 2026 at 12:44 PM IST<\/p>\n<section class=\"univest-login-cta\" style=\"margin:28px 0;padding:24px;border-radius:10px;background:#eef5ff;border:1px solid #cddff7;text-align:center\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Explore_mutual_funds_with_Univest\"><\/span>Explore mutual funds with Univest<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Review mutual fund data, compare performance and explore fund insights on Univest.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\" style=\"display:inline-block;padding:11px 20px;border-radius:6px;background:#1f4e79;color:#fff !important;text-decoration:none;font-weight:700\">Explore Univest<\/a><\/p>\n<\/section>\n<section class=\"univest-disclaimer\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"RIA_disclosure\"><\/span>RIA disclosure<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. This review is prepared by Uniapps Investment Adviser Pvt. Ltd. (earlier known as Uniapps Global Research Pvt. Ltd.) under SEBI Registered Investment Adviser registration INA000017639 for general informational purposes and is not personalized investment advice.<\/p>\n<\/section>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"InvestmentFund\",\"name\":\"Bandhan Healthcare Fund Direct Growth Plan\",\"identifier\":\"bandhan-healthcare-fund-g-direct-plan\",\"dateCreated\":\"28 Nov 2025\",\"isAccessibleForFree\":true,\"additionalProperty\":[{\"@type\":\"PropertyValue\",\"name\":\"NAV\",\"value\":11.237,\"valueReference\":\"as of 16 Sep 2026\"},{\"@type\":\"PropertyValue\",\"name\":\"AUM\",\"value\":\"331 Cr\"},{\"@type\":\"PropertyValue\",\"name\":\"Expense Ratio\",\"value\":\"0.0\"},{\"@type\":\"PropertyValue\",\"name\":\"Benchmark\",\"value\":\"Nifty 50\"},{\"@type\":\"PropertyValue\",\"name\":\"1Y Return\",\"value\":0},{\"@type\":\"PropertyValue\",\"name\":\"3Y Return\",\"value\":0},{\"@type\":\"PropertyValue\",\"name\":\"5Y Return\",\"value\":0},{\"@type\":\"PropertyValue\",\"name\":\"Fund Managers\",\"value\":\"Viraj Kulkarni, Brijesh Shah, Ritika Behera, Gaurav Satra\"}]}<\/script><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the current NAV of Bandhan Healthcare Fund Direct Growth Plan?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The current NAV is \u20b911.237 as of 16 September 2026.\"}},{\"@type\":\"Question\",\"name\":\"What are the fund\u2019s recent returns?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The fund\u2019s 1-month return is -0.64% and its 3-month return is 8.26%. The 1-year, 3-year and 5-year figures are not available for this scheme.\"}},{\"@type\":\"Question\",\"name\":\"How has the fund performed versus the benchmark?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It has done better than the benchmark over 3 months, where the fund returned 8.26% and the benchmark returned -3.6%. Over 1 month, the fund was -0.64% versus -4.41% for the benchmark.\"}},{\"@type\":\"Question\",\"name\":\"How does the fund compare with peers on available return data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The peer table shows 1-year gains for the other named funds, while this scheme does not yet have a usable 1-year trailing return. That makes the comparison more useful for context than for a direct like-for-like conclusion.\"}},{\"@type\":\"Question\",\"name\":\"Is there a minimum SIP?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, the minimum SIP is \u20b9100.\"}},{\"@type\":\"Question\",\"name\":\"What should investors know about the risk and portfolio?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The fund is tagged High Risk, and its largest holding is Sun Pharmaceutical Industries Limited at 10.48%. The top 10 holdings together account for 52.42% of the portfolio, so the scheme remains fairly focused.\"}}]}<\/script><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"Organization\",\"name\":\"Uniapps Investment Adviser Pvt. Ltd.\",\"description\":\"SEBI Registered Investment Adviser INA000017639\"}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bandhan Healthcare Fund Direct Growth Plan had a NAV of \u20b911.237 as of 16 September 2026 and scheme AUM of \u20b9331 Cr. Its recent returns are limited, but the 3-month return of 8.26% outpaced the benchmark.<\/p>\n","protected":false},"author":38,"featured_media":252603,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3841],"tags":[],"class_list":["post-252606","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mutual-funds"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["252603"],"rank_math_title":["Bandhan Healthcare Fund Review 2026 | NAV &amp; Returns"],"rank_math_description":["Bandhan Healthcare Fund Direct Growth Plan NAV is \u20b911.237. Its 3-month return is 8.26% as of 16 Sep 2026."],"rank_math_focus_keyword":["Bandhan Healthcare Fund Direct Growth Plan review"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Bandhan_Healthcare_Fund_Direct_Growth_Review_2026_NAV_Returns_Portfolio_Should_You_Invest_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/252606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=252606"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/252606\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/252603"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=252606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=252606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=252606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}